World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $716.59bn | 74.91 | 0.6% |
NOVO BNovo Nordisk A/S | DKK4.03tn | 47.59 | 1.04% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $381.02bn | 18.98 | 2.97% |
ABBVAbbvie | $314.22bn | 39.16 | 3.33% |
MRKMerck & Co | $307.77bn | 88.81 | 2.44% |
ROGRoche Holding AG | CH₣184.00bn | 12.83 | 4.16% |
RORoche Holding AG | CH₣184.00bn | 13.48 | 3.96% |
AZNAstraZeneca | £159.58bn | 38.47 | 2.21% |
NOVNNovartis AG | CH₣175.05bn | 17.79 | 4.05% |
PFEPfizer | $158.21bn | 8.81 | 5.87% |
AMGNAmgen | $144.09bn | 21.03 | 3.17% |
SANSanofi SA | €110.37bn | 16.69 | 4.26% |
CELG RTBristol-Myers Squibb Co | $105.84bn | 0.02 | 3831.93% |
BMYBristol-Myers Squibb Co | $105.84bn | 13.96 | 4.36% |
ODTCOdonate | $98.67bn | n/a | n/a |
GILDGilead Sciences | $91.80bn | 15.11 | 4.07% |
CSLCSL | AU$135.37bn | 34.82 | 1.39% |
GSKGSK | £67.91bn | 11.76 | 3.52% |
ZTSZoetis | $79.01bn | 33.43 | 0.87% |